Latest news
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 11:49:13 GMTPfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance - Business WireBusiness Wire · Tue, 04 Aug 2026 10:45:00 GMTPfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo - Business WireBusiness Wire · Thu, 30 Jul 2026 07:00:00 GMTEuropean Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union - Business WireBusiness Wire · Wed, 29 Jul 2026 07:00:00 GMT